January 15, 2020
Switzerland-based Type 2 diabetes treatment provider Oviva announced it has raised $21 million (€18.8 million) in Series B funding.
The round was led by Swiss healthtech investor MTIP, joined by Earlybird as new investors. Existing investors AlbionVC, F-Prime Capital, Eight Roads Ventures and Partech all participated.
It brings the total amount raised by Oviva to date to $34 million (€30.5...
December 4, 2019
Grenoble, France-based startup Diabeloop has secured €31m in a Series B funding round led by Cemag Invest, with ADAG, Odyssée Venture, previous backers Supernova Invest, Air Liquide Venture Capital and others also participating.
WHAT THEY DO
Founded in 2015 out of a medical research project, the company’s primary product is what is referred to as a hybrid closed-loop system for management of Type...